Key result
Diabetic cardiomyopathy involves multiple cell-death pathways, with biopsied hearts showing ~85-fold higher cardiomyocyte apoptosis.
Why the study?
Cardiomyocyte death accelerates the progression of diabetic cardiomyopathy to heart failure, highlighting the need to summarize updated data on the pathophysiological roles of multiple cell death forms.
This review highlights the pathophysiological roles of multiple forms of programmed cell death in diabetic cardiomyopathy and suggests that targeting these pathways may offer protective effects.
Answers are grounded in this paper and cite their sources.
May support targeting cell death pathways in diabetic cardiomyopathy; leaves open whether inhibition improves patient outcomes.
Diabetic mellitus (DM) is a common degenerative chronic metabolic disease often accompanied by severe cardiovascular complications (DCCs) as major causes of death in diabetic patients with diabetic cardiomyopathy (DCM) as the most common DCC. The metabolic disturbance in DCM generates the conditions/substrates and inducers/triggers and activates the signaling molecules and death executioners leading to cardiomyocyte death which accelerates the development of DCM and the degeneration of DCM to heart failure. Various forms of programmed active cell death including apoptosis, pyroptosis, autophagic cell death, autosis, necroptosis, ferroptosis and entosis have been identified and characterized in many types of cardiac disease. Evidence has also been obtained for the presence of multiple forms of cell death in DCM. Most importantly, published animal experiments have demonstrated that suppression of cardiomyocyte death of any forms yields tremendous protective effects on DCM. Herein, we provide the most updated data on the subject of cell death in DCM, critical analysis of published results focusing on the pathophysiological roles of cell death, and pertinent perspectives of future studies.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2021) conducted a review in Diabetic cardiomyopathy. Multiple forms of programmed cell death, including apoptosis and pyroptosis, contribute to diabetic cardiomyopathy, with biopsied patient hearts expressing 85-fold more cardiomyocyte apoptosis.
Synapse has enriched 10 related papers. Consider them for comparative context: